|

EBV-specific T cells: A Clinical Trials

1 actively recruiting trial across 1 location

Also known as: LMP, BARF1 and EBNA1 specific CTLs

Pipeline

Phase 1: 1

Top Sponsors

  • Baylor College of Medicine1

Indications

  • Lymphoproliferative Disease1
  • Hodgkin's Disease1
  • Non-Hodgkin's Lymphoma1
  • Lymphoma1
  • Cancer1

Houston, Texas1 trial

Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

Harris Health System (includes ben Taub General Hospital and Smith)

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.